| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 993 | 2022 |
| Homologous and heterologous Covid-19 booster vaccinations RL Atmar, KE Lyke, ME Deming, LA Jackson, AR Branche, HM El Sahly, ... New England Journal of Medicine 386 (11), 1046-1057, 2022 | 515 | 2022 |
| SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination R Pajon, NA Doria-Rose, X Shen, SD Schmidt, S O’Dell, C McDanal, ... New England Journal of Medicine 386 (11), 1088-1091, 2022 | 369 | 2022 |
| Structural diversity of the SARS-CoV-2 Omicron spike SMC Gobeil, R Henderson, V Stalls, K Janowska, X Huang, A May, ... Molecular cell 82 (11), 2050-2068. e6, 2022 | 160 | 2022 |
| Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant KE Lyke, RL Atmar, CD Islas, CM Posavad, D Szydlo, RP Chourdhury, ... Cell Reports Medicine 3 (7), 2022 | 146 | 2022 |
| Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge T Bradley, J Pollara, S Santra, N Vandergrift, S Pittala, C Bailey-Kellogg, ... Nature communications 8 (1), 15711, 2017 | 139 | 2017 |
| Targeted selection of HIV-specific antibody mutations by engineering B cell maturation KO Saunders, K Wiehe, M Tian, P Acharya, T Bradley, SM Alam, EP Go, ... Science 366 (6470), eaay7199, 2019 | 137 | 2019 |
| Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models KO Saunders, LK Verkoczy, C Jiang, J Zhang, R Parks, H Chen, ... Cell reports 21 (13), 3681-3690, 2017 | 103 | 2017 |
| Heterologous SARS-CoV-2 booster vaccinations–preliminary report RL Atmar, KE Lyke, ME Deming, LA Jackson, AR Branche, HM El Sahly, ... MedRxiv, 2021 | 95 | 2021 |
| Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide SM Alam, B Aussedat, Y Vohra, RR Meyerhoff, EM Cale, WE Walkowicz, ... Science translational medicine 9 (381), eaai7521, 2017 | 93 | 2017 |
| Booster of mRNA-1273 strengthens SARS-CoV-2 Omicron neutralization NA Doria-Rose, X Shen, SD Schmidt, S O’Dell, C McDanal, W Feng, ... MedRxiv, 2021 | 87 | 2021 |
| Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations WB Williams, J Zhang, C Jiang, NI Nicely, D Fera, K Luo, MA Moody, ... Nature communications 8 (1), 1732, 2017 | 84 | 2017 |
| Maternal HIV-1 envelope–specific antibody responses and reduced risk of perinatal transmission SR Permar, Y Fong, N Vandergrift, GG Fouda, P Gilbert, R Parks, ... The Journal of clinical investigation 125 (7), 2702-2706, 2015 | 83 | 2015 |
| Cryo-EM structures of SARS-CoV-2 Omicron BA. 2 spike V Stalls, J Lindenberger, SMC Gobeil, R Henderson, R Parks, M Barr, ... Cell Reports 39 (13), 2022 | 81 | 2022 |
| Vaccine elicitation of high mannose-dependent neutralizing antibodies against the V3-glycan broadly neutralizing epitope in nonhuman primates KO Saunders, NI Nicely, K Wiehe, M Bonsignori, RR Meyerhoff, R Parks, ... Cell reports 18 (9), 2175-2188, 2017 | 74 | 2017 |
| Immune Assays Team § ; Moderna, Inc. Team § ; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE) Team § ; United States Government (USG)/CoVPN … PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 68 | 2022 |
| Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates KO Saunders, N Pardi, R Parks, S Santra, Z Mu, L Sutherland, R Scearce, ... npj Vaccines 6 (1), 50, 2021 | 68 | 2021 |
| Booster of mRNA-1273 vaccine reduces SARS-CoV-2 Omicron escape from neutralizing antibodies NA Doria-Rose, X Shen, SD Schmidt, S O’Dell, C McDanal, W Feng, ... MedRxiv, 2021 | 64 | 2021 |
| Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition PB Gilbert, Y Huang, AC deCamp, S Karuna, Y Zhang, CA Magaret, ... Nature Medicine 28 (9), 1924-1932, 2022 | 61 | 2022 |
| Structural constraints of vaccine-induced tier-2 autologous HIV neutralizing antibodies targeting the receptor-binding site T Bradley, D Fera, J Bhiman, L Eslamizar, X Lu, K Anasti, R Zhang, ... Cell reports 14 (1), 43-54, 2016 | 60 | 2016 |
